| Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): Randomised, double-blind … RHJ Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M ... The Lancet 364 (9431), 331-7, 2004 | 2599 | 2004 |
| Comparison of triflusal and aspirin for prevention of vascular events in patients after cerebral infarction: the TACIP Study: a randomized, double-blind, multicenter trial MT Matías-Guiu J, Ferro JM, Alvarez-Sabín J, Torres F, Jiménez MD, Lago A Stroke. 2003 Apr;34(4):840-8. 34 (4), 840-8. doi: 10.1161/01.STR.0000063141.24, 2003 | 202* | 2003 |
| Should we expect neurological symptoms in the SARS-CoV-2 epidemic? J Matías-Guiu, U Gomez-Pinedo, P Montero-Escribano, P Gomez-Iglesias, ... Neurología (English Edition) 35 (3), 170-175, 2020 | 171* | 2020 |
| Efficacy and tolerability in migraine prophylaxis of flunarizine in reduced doses: a comparison with propranolol 160 mg daily. DBF Diener HC, Matias-Guiu J, Hartung E, Pfaffenrath V, Ludin HP, Nappi G Cephalalgia 22 (3), 209-21, 2002 | 160 | 2002 |
| One-year prevalence of migraine in Spain: a nationwide population-based survey J Matías-Guiu, J Porta-Etessam, V Mateos, S Díaz-Insa, A Lopez-Gil, ... Cephalalgia 31 (4), 463-470, 2011 | 149 | 2011 |
| Anti-CD20 and COVID-19 in multiple sclerosis and related disorders: a case series of 60 patients from Madrid, Spain P Montero-Escribano, J Matías-Guiu, P Gómez-Iglesias, J Porta-Etessam, ... Multiple sclerosis and related disorders 42, 102185, 2020 | 144 | 2020 |
| Placebo-controlled trial of nimodipine in the treatment of acute ischemic cerebral infarction MLJM Martínez-Vila E, Guillén F, Villanueva JA, Matías-Guiu J, Bigorra J ... Stroke. 21 (7), 1203-8, doi: 10.1161/01.str.21.7.1023., 1990 | 140* | 1990 |
| Potential of chitosan and its derivatives for biomedical applications in the central nervous system DD Ojeda-Hernández, AA Canales-Aguirre, J Matias-Guiu, ... Frontiers in Bioengineering and Biotechnology 8, 389, 2020 | 131 | 2020 |
| Triflusal for preventing serious vascular events in people at high risk TF Costa J, Ferro JM, Matias-Guiu J, Alvarez-Sabin J Cochrane Database Syst Rev. 2005 (3), CD004296. doi: 10.1002/14651858.CD004296, 2005 | 127* | 2005 |
| Cognitive dysfunction associated with COVID-19: A comprehensive neuropsychological study C Delgado-Alonso, M Valles-Salgado, A Delgado-Álvarez, M Yus, ... Journal of Psychiatric Research 150, 40-46, 2022 | 112 | 2022 |
| Comparative diagnostic accuracy of the ACE-III, MIS, MMSE, MoCA, and RUDAS for screening of Alzheimer disease JA Matías-Guiu, M Valles-Salgado, T Rognoni, F Hamre-Gil, ... Dementia and geriatric cognitive disorders 43 (5-6), 237-246, 2017 | 106 | 2017 |
| Management of atherothrombosis with clopidogrel in high-risk patients with recent transient ischaemic attack or ischaemic stroke (MATCH): study design and baseline data RHJ Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M ... Cerebrovasc Dis. 253-61. doi: 10.1159/000076962. 17 (2-3), 253-61. doi: 10 …, 2004 | 103* | 2004 |
| Addenbrooke's cognitive examination III: diagnostic utility for mild cognitive impairment and dementia and correlation with standardized neuropsychological tests JA Matias-Guiu, A Cortés-Martínez, M Valles-Salgado, T Rognoni, ... International psychogeriatrics 29 (1), 105-113, 2017 | 99 | 2017 |
| Astrocytes in neurodegenerative diseases (I): function and molecular description MGJ Guillamón-Vivancos T, Gómez-Pinedo U Neurologia 30 (3), 119-29. doi: 10.1016/j.nrl.2012.12.007, 2015 | 99 | 2015 |
| ACE2, TMPRSS2, and Furin variants and SARS‐CoV‐2 infection in Madrid, Spain L Torre‐Fuentes, J Matías‐Guiu, L Hernández‐Lorenzo, ... Journal of medical virology 93 (2), 863-869, 2021 | 97 | 2021 |
| Ischemic stroke in young adults I. Analysis of the etiological subgroups J Alvarez, J Matias‐Guiu, J Sumalla, M Molins, R Insa, JM Molto, R Martin, ... Acta neurologica scandinavica 80 (1), 28-34, 1989 | 93 | 1989 |
| Infection mechanism of SARS-COV-2 and its implication on the nervous system EE Reza-Zaldívar, MA Hernández-Sapiéns, B Minjarez, U Gomez-Pinedo, ... Frontiers in immunology 11, 621735, 2021 | 89 | 2021 |
| Pharmacodynamics of atabecestat (JNJ-54861911), an oral BACE1 inhibitor in patients with early Alzheimer’s disease: randomized, double-blind, placebo-controlled study M Timmers, JR Streffer, A Russu, Y Tominaga, H Shimizu, A Shiraishi, ... Alzheimer's research & therapy 10, 1-18, 2018 | 88 | 2018 |
| Spectrum of headaches associated with SARS‐CoV‐2 infection: study of healthcare professionals J Porta‐Etessam, JA Matías‐Guiu, N González‐García, P Gómez Iglesias, ... Headache: The Journal of Head and Face Pain 60 (8), 1697-1704, 2020 | 83 | 2020 |
| Management of neurological care during the COVID-19 pandemic J Matías-Guiu, J Porta-Etessam, E Lopez-Valdes, I Garcia-Morales, ... Neurología (English Edition) 35 (4), 233-237, 2020 | 82* | 2020 |
Jordi A Matias-GuiuHospital Clínico San CarlosZweryfikowany adres z salud.madrid.org
